RxDoctor Payments Data

Mandi Beman, MD

Gynecology · Denver, CONPI 1154467793

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 66.2% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $17,662 and has fallen 81.9% since, to $3,201 in 2025. Among gynecology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,726in general payments, 2019–2025

Across 110 payments — averaging $261.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$19K
  • Hologic Sales And Service, LLC$6K
  • Intuitive Surgical$2K
  • Gynesonics, Inc.$383
  • Bolder Surgical LLC$200
  • Covidien LP$111
  • plus $680 from 17 others

What the payments were for

  • Consulting fees$5,93821%
  • Speaking & faculty fees$16,00056%
  • Travel & lodging$2,6109%
  • Food & beverage$2,6799%
  • Education$1,5005%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,726 in reported general payments places this provider in the 95th percentile of 31 gynecology providers in Colorado.

See all gynecology providers in Colorado

Medicare billing

Part B allowed, 2024
$5,803
Medicare patients
31
Services billed
208

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol21$3,278

Paid to pharmacies, not to this prescriber.

Other gynecology in Denver

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →